![Sample our Engineering & Technology journals, sign in here to start your access, latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5933/TOC-Subject-Sample-2021-Engineering-Tech.jpg"})
Biography
Binodh DeSilva, PhD Vice President Analytical Strategy & Operations at Bristol-Myer Squibb (BMS) Company in New Brunswick, NJ, USA. She is responsible for leading the regulated analytical (small and large molecule), microbiology and industrial hygiene laboratories as well as the Chemistry, Manufacturing & Controls (CMC) regulatory document management functions in Product Development. She received her Bachelor's in Analytical Chemistry from the University of Colombo, Sri Lanka in 1987, and a PhD in Chemistry (Bioanalytical) in 1994 from the University of Kansas. She was a Post-Doctoral Research Associate in the Pharmaceutical Chemistry Department at the University of Kansas from 1994 to 1995. She was at Procter & Gamble Pharmaceuticals, Norwich, NY, USA, from 1995 to 2001 and at Amgen, Thousand Oaks, CA, USA leading the bioanalytical team from 2001 to 2010. She joined BMS in November of 2010. Dr DeSilva is the Past President of the American Association of Pharmaceutical Scientists. In addition, she is a member of the American Chemical Society, Association for Women in Science, and the Health Care Business Women's Association NY/NJ metro chapter.
Disclaimer
The opinions expressed in this interview are those of the interviewee and do not necessarily reflect the views of Future Science Group.
Financial & competing interests disclosure
The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.